The treatment of inflammatory arthritis with methotrexate in clinical practice: treatment duration and incidence of adverse drug reactions.

@article{Kinder2005TheTO,
  title={The treatment of inflammatory arthritis with methotrexate in clinical practice: treatment duration and incidence of adverse drug reactions.},
  author={A J Kinder and Andrew B. Hassell and J. -M. Brand and Ann Brownfield and Mette Charlotte Grove and Michael F Shadforth},
  journal={Rheumatology},
  year={2005},
  volume={44 1},
  pages={61-6}
}
OBJECTIVE To identify the proportion of patients with inflammatory arthritis who remain on methotrexate in the medium to long term and the incidence of side-effects in clinical practice. METHOD The study population comprised all patients with inflammatory arthritis treated with methotrexate and monitored in clinics under the auspices of Staffordshire Rheumatology Centre. Two clinical auditors collected data retrospectively from the computer database used to support monitoring of patients on… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 51 extracted citations

Immunosuppressive and cytotoxic therapy: pharmacology, toxicities, and monitoring.

Seminars in respiratory and critical care medicine • 2011
View 7 Excerpts
Highly Influenced

References

Publications referenced by this paper.
Showing 1-10 of 17 references

Comparative study of intramuscular gold and methotrexate in a rheumatoid arthritis population from a socially deprived area

J Hamiliton, IB McInnes, EA Thomson
Ann Rheum Dis • 2001
View 1 Excerpt

Similar Papers

Loading similar papers…